---
title: "Semnur Pharmaceuticals, Inc. (SMNR.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SMNR.US/norm.md"
symbol: "SMNR.US"
name: "Semnur Pharmaceuticals, Inc."
parent: "https://longbridge.com/en/quote/SMNR.US.md"
datetime: "2026-03-17T06:30:16.998Z"
locales:
  - [en](https://longbridge.com/en/quote/SMNR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SMNR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SMNR.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/SMNR.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SMNR.US/norm.md)


# Semnur Pharmaceuticals, Inc. (SMNR.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0283 | -0.7566 | -0.0062 | -0.0042 | -0.0039 |
| ROE | 139.38% | 2067.60% | 9.09% | - | - |
| Revenue | - | - | - | - | - |
| Net income | -6.16M | -152.59M | -999000.00 | -665000.00 | -776000.00 |
| Operating income | -6.16M | -152.59M | -999000.00 | -665000.00 | -776000.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | -372.76% | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.35M | 774000.00 | 9.08M | 7.51M | 6.68M |
| Leverage | -0.0649 | -0.0530 | -0.2043 | -0.1729 | -0.1562 |
| BVPS | -0.0901 | -0.0635 | -0.2778 | -0.2716 | -0.2674 |
| Turnover | - | - | - | - | - |
| Cash & STI | 20000.00 | 85000.00 | 55000.00 | 7000.00 | 12000.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | 750000.00 | 689000.00 | 689000.00 | 689000.00 | 689000.00 |
| Net debt | 15.43M | 9.73M | 52.12M | 50.75M | 49.42M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.60M | -2.13M | 268000.00 | -399000.00 | -1.41M |
| Investing CF | - | - | - | - | - |
| Financing CF | 3.54M | 2.16M | -220000.00 | 394000.00 | 1.41M |
| Free CF | -1.30M | 57.35M | -875375.00 | - | - |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | -4.06M | 7.38M | 1.30M | 1.23M | -2.17M |
| CapEx | - | - | - | - | - |